These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39135171)

  • 1. A scoping review of the use of minimally important difference of EQ-5D utility index and EQ-VAS scores in health technology assessment.
    Shaw C; Longworth L; Bennett B; McEntee-Richardson L; Shaw JW
    Health Qual Life Outcomes; 2024 Aug; 22(1):63. PubMed ID: 39135171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of the Use of EQ-5D for Clinical Outcome Assessment in Health Technology Assessment, Regulatory Claims, and Published Literature.
    Shaw C; Longworth L; Bennett B; McEntee-Richardson L; Shaw JW
    Patient; 2024 May; 17(3):239-249. PubMed ID: 38085457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review reveals that EQ-5D minimally important differences vary with treatment type and may decrease with increasing baseline score.
    Cheng LJ; Chen LA; Cheng JY; Herdman M; Luo N
    J Clin Epidemiol; 2024 Oct; 174():111487. PubMed ID: 39084578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Technology Assessment-Informed Decision Making by the Federal Joint Committee/Institute for Quality and Efficiency in Health Care in Germany and the National Institute for Health and Care Excellence in England: The Role of Budget Impact.
    Schaefer R; Hernández D; Bärnighausen T; Kolominsky-Rabas P; Schlander M
    Value Health; 2023 Jul; 26(7):1032-1044. PubMed ID: 36921901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the EQ-5D-5L, EQ-VAS stand-alone component and Oxford knee score in the Australian knee arthroplasty population utilising minimally important difference, concurrent validity, predictive validity and responsiveness.
    Lin DY; Cheok TS; Kaambwa B; Samson AJ; Morrison C; Chan T; Kroon HM; Jaarsma RL
    Health Qual Life Outcomes; 2023 May; 21(1):41. PubMed ID: 37165364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease.
    Bae E; Choi SE; Lee H; Shin G; Kang D
    BMC Pulm Med; 2020 Mar; 20(1):73. PubMed ID: 32293387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer.
    Pickard AS; Neary MP; Cella D
    Health Qual Life Outcomes; 2007 Dec; 5():70. PubMed ID: 18154669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines.
    Kennedy-Martin M; Slaap B; Herdman M; van Reenen M; Kennedy-Martin T; Greiner W; Busschbach J; Boye KS
    Eur J Health Econ; 2020 Nov; 21(8):1245-1257. PubMed ID: 32514643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients.
    Siriwardana AN; Hoffman AT; Morton RL; Smyth B; Brown MA
    Value Health; 2024 Apr; 27(4):469-477. PubMed ID: 38307389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study.
    Kuan WC; Chee KH; Kasim S; Lim KK; Dujaili JA; Lee KK; Teoh SL
    J Med Econ; 2024; 27(1):607-617. PubMed ID: 38557412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.
    Harvie HS; Honeycutt AA; Neuwahl SJ; Barber MD; Richter HE; Visco AG; Sung VW; Shepherd JP; Rogers RG; Jakus-Waldman S; Mazloomdoost D;
    Am J Obstet Gynecol; 2019 Mar; 220(3):265.e1-265.e11. PubMed ID: 30471259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke.
    Kim SK; Kim SH; Jo MW; Lee SI
    Health Qual Life Outcomes; 2015 Mar; 13():32. PubMed ID: 25889191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand.
    Dritsaki M; Petrou S; Williams M; Lamb SE
    Health Qual Life Outcomes; 2017 Jan; 15(1):20. PubMed ID: 28118833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial.
    Anderson RT; Baran RW; Erickson P; Revicki DA; Dietz B; Gooch K
    Qual Life Res; 2014 Apr; 23(3):877-86. PubMed ID: 24036634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference.
    Nolan CM; Longworth L; Lord J; Canavan JL; Jones SE; Kon SS; Man WD
    Thorax; 2016 Jun; 71(6):493-500. PubMed ID: 27030578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for the comparative evaluation of pharmaceuticals.
    Zentner A; Velasco-Garrido M; Busse R
    GMS Health Technol Assess; 2005 Nov; 1():Doc09. PubMed ID: 21289930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of the Methods Used to Generate Utility Values in NICE Technology Assessments for Children and Adolescents.
    Hill H; Rowen D; Pennington B; Wong R; Wailoo A
    Value Health; 2020 Jul; 23(7):907-917. PubMed ID: 32762993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of an Instrument-Defined Minimally Important Difference in EQ-5D-5L Index Scores Based on Scoring Algorithms Derived Using the EQ-VT Version 2 Valuation Protocols.
    Henry EB; Barry LE; Hobbins AP; McClure NS; O'Neill C
    Value Health; 2020 Jul; 23(7):936-944. PubMed ID: 32762996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the minimum clinically important difference in pain, disability, and quality of life after anterior cervical discectomy and fusion: clinical article.
    Parker SL; Godil SS; Shau DN; Mendenhall SK; McGirt MJ
    J Neurosurg Spine; 2013 Feb; 18(2):154-60. PubMed ID: 23176164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes.
    McClure NS; Sayah FA; Ohinmaa A; Johnson JA
    Value Health; 2018 Sep; 21(9):1090-1097. PubMed ID: 30224114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.